• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响多发性硬化症患者疲劳进展的因素。

Factors affecting fatigue progression in multiple sclerosis patients.

作者信息

Machtoub Dima, Fares Callie, Sinan Hassan, Al Hariri Moustafa, Nehme Rim, Chami Joelle, Joukhdar Ronny, Tcheroyan Raya, Adib Salim, Khoury Samia J

机构信息

Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

Department of Dermatology, American University of Beirut Medical Center, Beirut, Lebanon.

出版信息

Sci Rep. 2024 Dec 30;14(1):31682. doi: 10.1038/s41598-024-80992-0.

DOI:10.1038/s41598-024-80992-0
PMID:39738166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11686268/
Abstract

Fatigue is one of the most prevalent and disabling symptoms among patients with MS, but there is limited research investigating the longitudinal determinants of fatigue progression. This study aims to identify the sociodemographic, behavioral and clinical characteristics, and therapeutic regimens that are correlated with worsening fatigue over time in patients diagnosed with MS. This is a retrospective chart review of 483 patients. The primary outcome was a change in the Modified Fatigue Impact Scale-5 (MFIS-5) score from first to last visit during the study interval, from November 2018 to November 2020. The study found that progressive MS subtypes, worsening depression, worsening pain, use of antidepressants, and use of fatigue medications were significantly associated with negative fatigue outcomes. Meanwhile age, sex, smoking frequency, use of pain medications, disease-modifying therapies, BMI, number of relapses, visits, steroid courses, and co-morbidities did not show an association. The clinical characteristics associated with worsening fatigue include progressive MS subtypes, worsening depression, worsening pain, use of antidepressants, and use of fatigue medications. Further studies are needed in order to elucidate a causal relationship and determine whether the management of fatigue in patients with MS should include interventions that address the aforementioned variables to optimize patient care and improve quality of life.

摘要

疲劳是多发性硬化症(MS)患者中最普遍且致残的症状之一,但针对疲劳进展的纵向决定因素的研究有限。本研究旨在确定与确诊为MS的患者随时间推移疲劳加重相关的社会人口学、行为和临床特征以及治疗方案。这是一项对483例患者的回顾性病历审查。主要结局是在2018年11月至2020年11月的研究期间,从首次就诊到末次就诊时改良疲劳影响量表-5(MFIS-5)评分的变化。研究发现,进展型MS亚型、抑郁加重、疼痛加重、使用抗抑郁药以及使用抗疲劳药物与负面疲劳结局显著相关。同时,年龄、性别、吸烟频率、使用止痛药物、疾病修正治疗、体重指数、复发次数、就诊次数、类固醇疗程以及合并症均未显示出相关性。与疲劳加重相关的临床特征包括进展型MS亚型、抑郁加重、疼痛加重、使用抗抑郁药以及使用抗疲劳药物。需要进一步研究以阐明因果关系,并确定MS患者的疲劳管理是否应包括针对上述变量的干预措施,以优化患者护理并改善生活质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/11686268/a677f56c042f/41598_2024_80992_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/11686268/a677f56c042f/41598_2024_80992_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/206a/11686268/a677f56c042f/41598_2024_80992_Fig1_HTML.jpg

相似文献

1
Factors affecting fatigue progression in multiple sclerosis patients.影响多发性硬化症患者疲劳进展的因素。
Sci Rep. 2024 Dec 30;14(1):31682. doi: 10.1038/s41598-024-80992-0.
2
Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey.多发性硬化症的疲劳特征:北美多发性硬化症研究委员会(NARCOMS)调查
Health Qual Life Outcomes. 2008 Nov 14;6:100. doi: 10.1186/1477-7525-6-100.
3
Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters.多发性硬化症中的疲劳:不同评定量表的比较及其与临床参数的相关性
Mult Scler. 2002 Dec;8(6):523-6. doi: 10.1191/1352458502ms839oa.
4
Depression and fatigue in patients with multiple sclerosis.多发性硬化症患者的抑郁和疲劳。
J Neurol Sci. 2017 Sep 15;380:236-241. doi: 10.1016/j.jns.2017.07.047. Epub 2017 Jul 31.
5
Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.低脂、植物性饮食对多发性硬化症的影响:一项随机对照试验。
Mult Scler Relat Disord. 2016 Sep;9:80-90. doi: 10.1016/j.msard.2016.07.001. Epub 2016 Jul 6.
6
Fatigue and depression predict quality of life in patients with early multiple sclerosis: a longitudinal study.疲劳和抑郁可预测早期多发性硬化症患者的生活质量:一项纵向研究。
Eur J Neurol. 2016 Sep;23(9):1482-6. doi: 10.1111/ene.13102. Epub 2016 Jul 14.
7
Exploring the Impact of Fatigue in Progressive Multiple Sclerosis: A Mixed-Methods Analysis.探索疲劳在进展性多发性硬化症中的影响:一项混合方法分析。
Mult Scler Relat Disord. 2020 Aug;43:102207. doi: 10.1016/j.msard.2020.102207. Epub 2020 May 27.
8
Prevalence, treatment and correlates of depression in multiple sclerosis.多发性硬化症中抑郁的患病率、治疗方法及相关因素。
Mult Scler Relat Disord. 2024 Jul;87:105648. doi: 10.1016/j.msard.2024.105648. Epub 2024 Apr 26.
9
Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study.阿法骨化醇对多发性硬化症相关性疲劳的影响:一项随机、双盲、安慰剂对照研究。
Mult Scler. 2015 May;21(6):767-75. doi: 10.1177/1352458514554053. Epub 2014 Oct 24.
10
Treatment experience, burden, and unmet needs (TRIBUNE) in Multiple Sclerosis study: the costs and utilities of MS patients in The Netherlands.多发性硬化症研究中的治疗经验、负担和未满足的需求(论坛):荷兰多发性硬化症患者的成本和效用。
J Med Econ. 2013 Jul;16(7):939-50. doi: 10.3111/13696998.2013.807267. Epub 2013 Jun 12.

引用本文的文献

1
Open label placebo to treat fatigue in people with multiple sclerosis: feasibility and preliminary effects.开放标签安慰剂治疗多发性硬化症患者疲劳:可行性及初步效果
Pilot Feasibility Stud. 2025 Jul 3;11(1):93. doi: 10.1186/s40814-025-01674-w.
2
HERV Dysregulation in a Case of Myalgic Encephalomyelitis and Multiple Sclerosis Responsive to Rituximab.1例对利妥昔单抗有反应的肌痛性脑脊髓炎和多发性硬化症患者中的人内源性逆转录病毒失调
Int J Mol Sci. 2025 May 20;26(10):4885. doi: 10.3390/ijms26104885.

本文引用的文献

1
Severity and worsening of fatigue among individuals with multiple sclerosis.多发性硬化症患者疲劳的严重程度及病情恶化情况。
Mult Scler J Exp Transl Clin. 2023 Apr 18;9(2):20552173231167079. doi: 10.1177/20552173231167079. eCollection 2023 Apr-Jun.
2
Choosing the most appropriate cut-point for continuous variables.为连续变量选择最合适的切点。
Rev Col Bras Cir. 2022 Jul 25;49:e20223346. doi: 10.1590/0100-6991e-20223346-en. eCollection 2022.
3
Co-occurrence of Fatigue and Depression in People With Multiple Sclerosis: A Mini-Review.
多发性硬化症患者疲劳与抑郁的共现:一项小型综述。
Front Neurol. 2022 Feb 15;12:817256. doi: 10.3389/fneur.2021.817256. eCollection 2021.
4
Prevalence, co-occurrence, and trajectories of pain, fatigue, depression, and anxiety in the year following multiple sclerosis diagnosis.多发性硬化症诊断后一年内疼痛、疲劳、抑郁和焦虑的患病率、共现情况及发展轨迹。
Mult Scler. 2022 Apr;28(4):620-631. doi: 10.1177/13524585211023352. Epub 2021 Jun 16.
5
Antidepressants on Multiple Sclerosis: A Review of and Models.抗抑郁药与多发性硬化症: 与 模型的综述。
Front Immunol. 2021 May 20;12:677879. doi: 10.3389/fimmu.2021.677879. eCollection 2021.
6
Epidemiology of multiple sclerosis in Lebanon: A rising prevalence in the middle east.黎巴嫩多发性硬化症的流行病学:中东地区发病率上升。
Mult Scler Relat Disord. 2021 Jul;52:102963. doi: 10.1016/j.msard.2021.102963. Epub 2021 Apr 20.
7
A longitudinal study of symptom botheration in Multiple Sclerosis.一项关于多发性硬化症症状困扰的纵向研究。
Mult Scler Relat Disord. 2020 Nov;46:102585. doi: 10.1016/j.msard.2020.102585. Epub 2020 Oct 17.
8
Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.金刚烷胺、莫达非尼和哌甲酯治疗多发性硬化疲劳的安全性和有效性:一项随机、安慰剂对照、交叉、双盲试验。
Lancet Neurol. 2021 Jan;20(1):38-48. doi: 10.1016/S1474-4422(20)30354-9. Epub 2020 Nov 23.
9
Assessing fatigue in multiple sclerosis: Psychometric properties of the five-item Modified Fatigue Impact Scale (MFIS-5).评估多发性硬化症中的疲劳:五项改良疲劳影响量表(MFIS-5)的心理测量特性。
Mult Scler J Exp Transl Clin. 2019 Nov 9;5(4):2055217319887987. doi: 10.1177/2055217319887987. eCollection 2019 Oct-Dec.
10
Fatigue in Multiple Sclerosis is related to relapses, autonomic dysfunctions and introversion: A quasi-experimental study.多发性硬化症中的疲劳与复发、自主神经功能障碍和内向有关:一项准实验研究。
Mult Scler Relat Disord. 2019 Nov;36:101401. doi: 10.1016/j.msard.2019.101401. Epub 2019 Sep 17.